Assenagon Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.6M Sell
153,459
-81,348
-35% -$17.8M 0.05% 252
2025
Q1
$52.6M Buy
234,807
+135,584
+137% +$30.4M 0.09% 191
2024
Q4
$32.5M Buy
99,223
+60,545
+157% +$19.8M 0.05% 258
2024
Q3
$11.6M Buy
38,678
+12,769
+49% +$3.83M 0.02% 472
2024
Q2
$8.53M Sell
25,909
-21,662
-46% -$7.14M 0.02% 452
2024
Q1
$18.8M Sell
47,571
-78,769
-62% -$31.2M 0.04% 273
2023
Q4
$44.5M Buy
126,340
+110,597
+703% +$38.9M 0.12% 132
2023
Q3
$5.91M Buy
15,743
+13,308
+547% +$4.99M 0.02% 511
2023
Q2
$931K Sell
2,435
-16,999
-87% -$6.5M ﹤0.01% 954
2023
Q1
$6.73M Sell
19,434
-209,729
-92% -$72.7M 0.02% 470
2022
Q4
$53.9M Buy
229,163
+100,008
+77% +$23.5M 0.19% 95
2022
Q3
$31.8M Buy
129,155
+106,723
+476% +$26.3M 0.12% 149
2022
Q2
$6.78M Buy
22,432
+15,686
+233% +$4.74M 0.03% 446
2022
Q1
$2.77M Buy
6,746
+533
+9% +$219K 0.01% 682
2021
Q4
$2.91M Sell
6,213
-21,192
-77% -$9.94M 0.01% 658
2021
Q3
$11.6M Buy
27,405
+22,651
+476% +$9.62M 0.04% 237
2021
Q2
$1.71M Sell
4,754
-1,605
-25% -$576K 0.01% 704
2021
Q1
$1.79M Sell
6,359
-11,511
-64% -$3.24M 0.01% 706
2020
Q4
$5.06M Buy
17,870
+13,287
+290% +$3.76M 0.02% 317
2020
Q3
$1.26M Sell
4,583
-35,632
-89% -$9.8M 0.01% 688
2020
Q2
$9.14M Buy
40,215
+29,107
+262% +$6.61M 0.06% 181
2020
Q1
$1.69M Buy
+11,108
New +$1.69M 0.01% 375
2019
Q3
Sell
-65,432
Closed -$8.19M 1054
2019
Q2
$8.19M Buy
65,432
+6,971
+12% +$872K 0.06% 155
2019
Q1
$6.44M Buy
+58,461
New +$6.44M 0.06% 224
2018
Q4
Sell
-35,165
Closed -$4.34M 1127
2018
Q3
$4.34M Buy
+35,165
New +$4.34M 0.04% 291